58 related articles for article (PubMed ID: 38440354)
1. Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression.
Mo X; Liu Q; Liang K; Song Y
J Bioenerg Biomembr; 2024 Jun; 56(3):333-345. PubMed ID: 38488992
[TBL] [Abstract][Full Text] [Related]
2. 4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancer.
Yin J; Chen J; Hong JH; Huang Y; Xiao R; Liu S; Deng P; Sun Y; Chai KXY; Zeng X; Chan JY; Guan P; Wang Y; Wang P; Tong C; Yu Q; Xia X; Ong CK; Teh BT; Xiong Y; Tan J
JCI Insight; 2024 Jun; ():. PubMed ID: 38842940
[TBL] [Abstract][Full Text] [Related]
3. Xinnaotongluo liquid protects H9c2 cells from H/R-induced damage by regulating MDM2/STEAP3.
Cui J; Wang Q; Li M
PLoS One; 2024; 19(4):e0302407. PubMed ID: 38640125
[TBL] [Abstract][Full Text] [Related]
4. Role of SLC7A11/xCT in Ovarian Cancer.
Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
[TBL] [Abstract][Full Text] [Related]
5. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Koppula P; Zhuang L; Gan B
Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
[TBL] [Abstract][Full Text] [Related]
6. STEAP3 Affects Ovarian Cancer Progression by Regulating Ferroptosis through the p53/SLC7A11 Pathway.
Han Y; Fu L; Kong Y; Jiang C; Huang L; Zhang H
Mediators Inflamm; 2024; 2024():4048527. PubMed ID: 38440354
[TBL] [Abstract][Full Text] [Related]
7. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
[TBL] [Abstract][Full Text] [Related]
8. STEAP3 Affects Ferroptosis and Progression of Renal Cell Carcinoma Through the p53/xCT Pathway.
Ye CL; Du Y; Yu X; Chen ZY; Wang L; Zheng YF; Liu XH
Technol Cancer Res Treat; 2022; 21():15330338221078728. PubMed ID: 35275508
[TBL] [Abstract][Full Text] [Related]
9. circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.
Qin K; Zhang F; Wang H; Wang N; Qiu H; Jia X; Gong S; Zhang Z
BMB Rep; 2023 Mar; 56(2):184-189. PubMed ID: 36617466
[TBL] [Abstract][Full Text] [Related]
10. Curcumin derivative NL01 induces ferroptosis in ovarian cancer cells via HCAR1/MCT1 signaling.
Shi M; Zhang MJ; Yu Y; Ou R; Wang Y; Li H; Ge RS
Cell Signal; 2023 Sep; 109():110791. PubMed ID: 37406786
[TBL] [Abstract][Full Text] [Related]
11. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
[TBL] [Abstract][Full Text] [Related]
12. Inhibit ALDH3A2 reduce ovarian cancer cells survival via elevating ferroptosis sensitivity.
Dong H; He L; Sun Q; Zhan J; Li J; Xiong X; Zhuang L; Wu S; Li Y; Yin C; He Q
Gene; 2023 Aug; 876():147515. PubMed ID: 37247796
[TBL] [Abstract][Full Text] [Related]
13. CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer.
Zhang X; Zheng X; Ying X; Xie W; Yin Y; Wang X
J Transl Med; 2023 May; 21(1):334. PubMed ID: 37210575
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
